Sequana Medical NV
SQNMF
$3.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -100.00% | -72.84% | -72.18% | -24.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -100.00% | -72.84% | -72.18% | -24.56% |
| Cost of Revenue | -99.51% | -99.51% | -70.95% | -70.04% | -21.43% |
| Gross Profit | -100.15% | -100.15% | -73.46% | -72.82% | -25.51% |
| SG&A Expenses | -32.74% | -31.38% | -36.82% | -35.33% | -4.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -32.77% | -31.52% | 32.92% | 31.29% | 1.71% |
| Total Operating Expenses | -37.36% | -36.10% | -39.30% | -37.86% | -3.93% |
| Operating Income | 35.90% | 34.61% | 38.46% | 37.00% | 3.31% |
| Income Before Tax | -108.38% | -112.57% | 33.29% | 31.71% | -6.11% |
| Income Tax Expenses | -36.63% | -35.28% | -43.56% | -42.25% | 71.41% |
| Earnings from Continuing Operations | -106.48% | -110.64% | 33.45% | 31.87% | -6.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.48% | -110.64% | 33.45% | 31.87% | -6.64% |
| EBIT | 35.90% | 34.61% | 38.46% | 37.00% | 3.31% |
| EBITDA | 36.07% | 34.78% | 38.79% | 37.34% | 3.45% |
| EPS Basic | -41.71% | -44.54% | 47.95% | 46.70% | 10.26% |
| Normalized Basic EPS | -43.00% | -45.87% | 47.82% | 46.55% | 10.71% |
| EPS Diluted | -41.71% | -44.54% | 47.95% | 46.70% | 10.26% |
| Normalized Diluted EPS | -43.00% | -45.87% | 47.82% | 46.55% | 10.71% |
| Average Basic Shares Outstanding | 45.70% | 45.70% | 27.83% | 27.83% | 18.84% |
| Average Diluted Shares Outstanding | 45.70% | 45.70% | 27.83% | 27.83% | 18.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |